Cargando…
Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. MET...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678649/ https://www.ncbi.nlm.nih.gov/pubmed/30702452 http://dx.doi.org/10.1097/PTS.0000000000000571 |
_version_ | 1783612200887255040 |
---|---|
author | Kapoor, Alok Landyn, Valentina Wagner, Joann Burgwinkle, Pamela Huang, Wei Gore, Joel Spencer, Frederick A. Goldberg, Robert McManus, David D. Darling, Chad Boudreaux, Edwin Barton, Bruce Mazor, Kathleen M. |
author_facet | Kapoor, Alok Landyn, Valentina Wagner, Joann Burgwinkle, Pamela Huang, Wei Gore, Joel Spencer, Frederick A. Goldberg, Robert McManus, David D. Darling, Chad Boudreaux, Edwin Barton, Bruce Mazor, Kathleen M. |
author_sort | Kapoor, Alok |
collection | PubMed |
description | The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful. |
format | Online Article Text |
id | pubmed-7678649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76786492020-11-23 Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism Kapoor, Alok Landyn, Valentina Wagner, Joann Burgwinkle, Pamela Huang, Wei Gore, Joel Spencer, Frederick A. Goldberg, Robert McManus, David D. Darling, Chad Boudreaux, Edwin Barton, Bruce Mazor, Kathleen M. J Patient Saf Original Articles The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful. Lippincott Williams & Wilkins 2020-12 2019-01-29 /pmc/articles/PMC7678649/ /pubmed/30702452 http://dx.doi.org/10.1097/PTS.0000000000000571 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Articles Kapoor, Alok Landyn, Valentina Wagner, Joann Burgwinkle, Pamela Huang, Wei Gore, Joel Spencer, Frederick A. Goldberg, Robert McManus, David D. Darling, Chad Boudreaux, Edwin Barton, Bruce Mazor, Kathleen M. Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title | Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title_full | Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title_fullStr | Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title_full_unstemmed | Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title_short | Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism |
title_sort | supplying pharmacist home visit and anticoagulation professional consultation during transition of care for patients with venous thromboembolism |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678649/ https://www.ncbi.nlm.nih.gov/pubmed/30702452 http://dx.doi.org/10.1097/PTS.0000000000000571 |
work_keys_str_mv | AT kapooralok supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT landynvalentina supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT wagnerjoann supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT burgwinklepamela supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT huangwei supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT gorejoel supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT spencerfredericka supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT goldbergrobert supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT mcmanusdavidd supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT darlingchad supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT boudreauxedwin supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT bartonbruce supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism AT mazorkathleenm supplyingpharmacisthomevisitandanticoagulationprofessionalconsultationduringtransitionofcareforpatientswithvenousthromboembolism |